Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Atara Biotherapeutics, Inc. | 290,794 | reported | 02 Mar 2023 | tx 29+1,164,350−69,169 |
| Gossamer Bio, Inc. | 46,500 | reported | 14 Feb 2020 | tx 9+224,994−83,988 |
| Pyxis Oncology, Inc. | 45,867 | reported | 24 Mar 2026 | tx 7+540,711 |
| OncoMed Pharmaceuticals Inc | 34,440 | reported | 09 Oct 2016 | tx 51+234,000−75,162 |
| Bolt Biotherapeutics, Inc. | 0 | reported | 12 Dec 2025 | tx 12+93,533−5,449 |
| Brookline Capital Acquisition Corp. | 0 | reported | 23 Aug 2023 | tx 4+100,000−154,573 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 24 Mar 2026 | GRANT_AWARD | Pyxis Oncology, Inc. | 45,867 | 0.00 USD | deriv |
| 12 Dec 2025 | OTHER | Bolt Biotherapeutics, Inc. | 849 | — | deriv |
| 12 Dec 2025 | OTHER | Bolt Biotherapeutics, Inc. | 1,000 | — | deriv |
| 12 Dec 2025 | GRANT_AWARD | Bolt Biotherapeutics, Inc. | 1,100 | — | deriv |
| 12 Dec 2025 | OTHER | Bolt Biotherapeutics, Inc. | 1,100 | — | deriv |
| 12 Dec 2025 | GRANT_AWARD | Bolt Biotherapeutics, Inc. | 849 | — | deriv |
| 12 Dec 2025 | OTHER | Bolt Biotherapeutics, Inc. | 2,500 | — | deriv |
| 12 Dec 2025 | GRANT_AWARD | Bolt Biotherapeutics, Inc. | 2,500 | — | deriv |
| 12 Dec 2025 | GRANT_AWARD | Bolt Biotherapeutics, Inc. | 1,000 | — | deriv |
| 27 May 2025 | GRANT_AWARD | Bolt Biotherapeutics, Inc. | 1,100 | 0.00 USD | deriv |
| 01 May 2025 | GRANT_AWARD | Bolt Biotherapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 31 Mar 2025 | GRANT_AWARD | Pyxis Oncology, Inc. | 36,979 | 0.98 USD | deriv |
| 03 Sept 2024 | GRANT_AWARD | Bolt Biotherapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 03 Sept 2024 | GRANT_AWARD | Bolt Biotherapeutics, Inc. | 16,984 | 0.00 USD | deriv |
| 26 Mar 2024 | GRANT_AWARD | Pyxis Oncology, Inc. | 38,741 | 0.00 USD | |
| 22 Sept 2023 | GRANT_AWARD | Pyxis Oncology, Inc. | 392,461 | 0.00 USD | deriv |
| 23 Aug 2023 | OTHER | Brookline Capital Acquisition Corp. | 20,489 | — | deriv |
| 23 Aug 2023 | OTHER | Brookline Capital Acquisition Corp. | 100,000 | — | deriv |
| 23 Aug 2023 | OTHER | Brookline Capital Acquisition Corp. | 34,084 | — | deriv |
| 23 Aug 2023 | GRANT_AWARD | Pyxis Oncology, Inc. | 5,879 | — | deriv |
| 23 Aug 2023 | GRANT_AWARD | Pyxis Oncology, Inc. | 3,534 | — | deriv |
| 23 Aug 2023 | GRANT_AWARD | Pyxis Oncology, Inc. | 17,250 | — | deriv |
| 02 Mar 2023 | SALE | Atara Biotherapeutics, Inc. | 5,074 | 3.63 USD | |
| 01 Mar 2023 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 141,328 | 0.00 USD | |
| 01 Mar 2023 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 317,987 | 0.00 USD | deriv |